Bio-Techne
TECH
#1510
Rank
C$16.75 B
Marketcap
$105.46
Share price
1.29%
Change (1 day)
8.15%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.11

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.28. In 2022 the company made an earnings per share (EPS) of $2.42 an increase over its 2021 EPS that were of $1.95.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-12.81%
2022$2.4224.35%
2021$1.9517.98%
2020$1.65-10.94%
2019$1.86101.57%
2018$0.92-17.53%
2017$1.1239.37%
2016$0.80-17.23%
2015$0.97-14.97%
2014$1.141.29%
2013$1.123.68%
2012$1.08-1.97%
2011$1.111.67%
2010$1.097.14%
2009$1.01-1.06%
2008$1.0319.41%
2007$0.8619.1%
2006$0.7210.56%
2005$0.6529.5%
2004$0.5013.05%
2003$0.4568.43%
2002$0.26-17.05%
2001$0.3217.33%
2000$0.2748.51%
1999$0.1823.17%
1998$0.1513.89%
1997$0.1342.57%
1996$0.09149

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.23 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.29-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.04 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.62 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.11-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$12.39 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.36-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA